Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.


Por: Puig-Barbera J, Guglieri-Lopez B, Tortajada-Girbes M, Lopez-Labrador FX, Carballido-Fernandez M, Mollar-Maseres J, Schwarz-Chavarri G, Baselga-Moreno V, Mira-Iglesias A, Diez-Domingo J and Valencia Hospital Network for the Study of Influenza, R

Publicada: 19 dic 2017 Ahead of Print: 8 nov 2017
Resumen:
The 2015/2016 influenza season was characterized in Europe by the circulation of A(H1N1)pdm09 clade 6B.1 and B/Victoria-lineage influenza viruses. The components of the vaccines used in the current and past two seasons in the Valencia region were similar but not well matched to the 2015/2016 dominant influenza-circulating strains. We estimate influenza vaccine effectiveness (IVE) and interference of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-lineage in this particular season.

Filiaciones:
Puig-Barbera J:
 Fundacion para el Fomento de la Investigacion Sanitaria y Biomedica de la Comunitat Valenciana (FISABIO), Valencia, Spain

 Centro de Salud Publica de Castellon, Castellon, Spain

Guglieri-Lopez B:
 Fundacion para el Fomento de la Investigacion Sanitaria y Biomedica de la Comunitat Valenciana (FISABIO), Valencia, Spain

Tortajada-Girbes M:
 Hospital Doctor Peset, Valencia, Spain

Lopez-Labrador FX:
 Fundacion para el Fomento de la Investigacion Sanitaria y Biomedica de la Comunitat Valenciana (FISABIO), Valencia, Spain

 Consorcio de Investigacion Biomedica de Epidemiologia y Salud Publica (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain

Carballido-Fernandez M:
 Hospital General Universitario de Castellon, Universidad CEU-UCH Castellon, Spain

Mollar-Maseres J:
 Hospital Universitario y Politécnico La Fe, Valencia, Spain

:
 Hospital General de Alicante, Alicante, Spain

Baselga-Moreno V:
 Fundacion para el Fomento de la Investigacion Sanitaria y Biomedica de la Comunitat Valenciana (FISABIO), Valencia, Spain

Mira-Iglesias A:
 Fundacion para el Fomento de la Investigacion Sanitaria y Biomedica de la Comunitat Valenciana (FISABIO), Valencia, Spain

Diez-Domingo J:
 Fundacion para el Fomento de la Investigacion Sanitaria y Biomedica de la Comunitat Valenciana (FISABIO), Valencia, Spain
ISSN: 13588745





Vaccine
Editorial
Elsevier BV, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND, Países Bajos
Tipo de documento: Article
Volumen: 35 Número: 52
Páginas: 7331-7338
WOS Id: 000418966400017
ID de PubMed: 29128380

MÉTRICAS